SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratories informs about quarterly statement of investor complaints

07 Jul 2016 Evaluate

Zenotech Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Zenotech Laboratorie Share Price

47.45 0.40 (0.85%)
11-May-2026 10:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1866.90
Dr. Reddys Lab 1277.10
Cipla 1339.45
Zydus Lifesciences 935.15
Lupin 2257.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×